Nektar Therapeutics
P/S (Price-to-Sales)
Price
Sales Per Share
P/S (Price-to-Sales)
| Fiscal Year | P/S (Price-to-Sales) | Sales Per Share | Price |
|---|---|---|---|
| Dec 2010 | 114.55x | $1.68 | $192.75 |
| Dec 2011 | 134.54x | $0.62 | $84.00 |
| Dec 2012 | 157.79x | $0.70 | $111.15 |
| Dec 2013 | 133.18x | $1.28 | $170.25 |
| Dec 2014 | 152.00x | $1.53 | $232.50 |
| Dec 2015 | 148.17x | $1.71 | $252.75 |
| Dec 2016 | 170.45x | $1.08 | $184.05 |
| Dec 2017 | 464.40x | $1.93 | $895.80 |
| Dec 2018 | 71.70x | $6.88 | $493.05 |
| Dec 2019 | 498.71x | $0.65 | $323.85 |
| Dec 2020 | 300.32x | $0.85 | $255.00 |
| Dec 2021 | 364.50x | $0.56 | $202.65 |
| Dec 2022 | 68.92x | $0.49 | $33.90 |
| Dec 2023 | 17.71x | $0.47 | $8.40 |
| Dec 2024 | 1.94x | $7.18 | $13.95 |
| Dec 2025 | 12.80x | $3.27 | $41.90 |